Australian Clinical Labs Limited (ASX: ACL)
Health Care · Health Care Providers & Services · AU
AU$2.94
+5.00% today · +19.0% 1Y
Australian Clinical Labs Limited (ASX: ACL) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $379.65M and employs 4,500 people.
Over the last twelve months the share price has gained 19.0%, trading between 1.83 and 3.03.
Tweenvest scores Australian Clinical Labs Limited across four factors: quality 69/100, value 52/100, growth 33/100, dividend 62/100. Its strongest factor is quality.
ACL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $379.65M
- Revenue (TTM)
- $509.27M
- P/E
- 23.84
- EPS
- 0.12
- Dividend yield
- 4.64%
- Beta (5Y)
- 0.82
- 52-week high
- AU$3.03
- 52-week low
- AU$1.83
- Avg volume (3M)
- —
- Shares outstanding
- 185.05M
- Employees
- 4,500
- Next earnings
- —
About Australian Clinical Labs Limited
Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
- ISIN
- AU0000148496
- Founded
- 2015
- Listed since
- May 14, 2021
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Voxel S.A.WSE: VOX | $389.23M | zł147.00 | +1.24% |
| Medicare Group Q.P.S.C.DSM: MCGS | $386.54M | QR5.00 | -2.63% |
| China Resources Medical Holdings Company LimitedSEHK: 1515 | $383.34M | HK$2.32 | +0.87% |
| Instituto de Diagnóstico S.A.SNSE: INDISA | $383.20M | CL$2,450.40 | -0.79% |
| Auna S.A.NYSE: AUNA | $378.95M | $5.16 | +0.78% |
| Community Health Systems, Inc.NYSE: CYH | $374.06M | $2.91 | +5.43% |
| American Oncology Network, Inc.OTCPK: AONC | $371.06M | $11.00 | +10.11% |
| Prenetics Global LimitedNasdaqGM: PRE | $369.92M | $21.28 | -2.56% |
Figures last refreshed Oct 11, 2026.